Virtus Biotech EtfBBP
Type
ETF
Peer group
US equity: Healthcare
Net assets
$59.3M
Expense ratio
0.34%
1-year return
+57.8%
3 years, a year
+26.1%
5 years, a year
+15.1%
Holdings
63
What it aims to do.
The Virtus Biotech ETF (formerly,Virtus LifeSci Biotech Products ETF) (the Fund ) seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Products Index (the Underlying Index ).
Top 10 holdings.
| Holding | % of fund |
|---|---|
| IBRX Immunitybio Inc | 4.80% |
| JOBY Dreyfus Government Cash Manage | 3.15% |
| Apellis Pharmaceuticals Inc | 2.59% |
| Kalvista Pharmaceuticals Inc | 2.52% |
| MRNA Moderna Inc | 2.49% |
| IOVA Iovance Biotherapeutics Inc | 2.44% |
| MIRM Mirum Pharmaceuticals Inc | 2.39% |
| AXSM Axsome Therapeutics Inc | 2.24% |
| JOBY Kiniksa Pharmaceuticals International Plc | 2.06% |
| JOBY Roivant Sciences Ltd | 2.06% |
More on BBP.
- BBP overview
- BBP holdings
- BBP risk
- BBP costs
- BBP money in and out
- BBP share classes
- Compare BBP with other funds
Returns after fees, from the fund's SEC filings up to Aug 2026. Past returns are not a promise. Not financial advice.